ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

CDXS Codexis Inc

3.92
0.00 (0.00%)
시간외 단일가
최종 업데이트: 17:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Codexis Inc CDXS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 3.92 17:00:00
개장가 저가 고가 종가 전일 종가
3.92
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/05/202405:05GLOBECodexis Reports First Quarter 2024 Financial Results
19/04/202405:05GLOBECodexis to Report First Quarter 2024 Financial Results on..
11/04/202420:05GLOBECodexis Appoints Carole Cobb, MBA, to Strategic Advisory..
07/03/202406:02EDGAR2Form 8-K - Current report
29/02/202406:05GLOBECodexis Reports Fourth Quarter and Fiscal Year 2023..
28/02/202402:15APSBiotech Rallied Strongly On Exclusive Licensing Agreement
27/02/202406:05GLOBECodexis Enters Exclusive Licensing Agreement for Newly..
26/02/202422:05GLOBECodexis to Participate in TD Cowen 44th Annual Health Care..
20/02/202422:05GLOBECodexis Announces Appointment of Masad Damha, PhD, and Jim..
17/02/202406:01EDGAR2Form 8-K - Current report
15/02/202406:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202406:05GLOBECodexis to Report Fourth Quarter and Fiscal Year 2023..
14/02/202406:19EDGAR2Form 8-K - Current report
14/02/202406:05GLOBECodexis Secures $40 Million in Strategic Financing Deal with..
10/02/202406:06EDGAR2Form 8-K - Current report
02/02/202406:05GLOBEseqWell and Codexis to Unveil Engineered Transposase Enzyme..
25/01/202404:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/01/202422:30EDGAR2Form 8-K - Current report
03/01/202411:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202411:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202411:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202411:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202322:30GLOBECodexis Announces Purchase Agreement with Nestlé Health..
27/12/202322:30EDGAR2Form 8-K - Current report
14/12/202306:06GLOBECodexis and Aldevron Enter Exclusive Licensing Agreement for..
14/12/202306:05GLOBECodexis Announces Achievement of Gram-scale Synthesis with..
11/12/202321:05GLOBECodexis KOL Event Highlights Significant Need for an..
29/11/202306:05GLOBECodexis to Host Virtual KOL Event on its ECO Synthesis™..
18/11/202307:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202307:31EDGAR2Form 144 - Report of proposed sale of securities
15/11/202306:05GLOBECodexis to Participate in 35th Annual Piper Sandler..
04/11/202305:26EDGAR2Form 8-K/A - Current report: [Amend]
04/11/202305:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202305:16EDGAR2Form 8-K - Current report
03/11/202305:05GLOBECodexis Reports Third Quarter 2023 Financial Results
01/11/202305:05GLOBECodexis to Participate in Upcoming Healthcare Conferences
28/10/202304:35GLOBECodexis to Present Update on ECO Synthesis™ Platform at..
27/10/202305:05GLOBECodexis to Present Update on ECO Synthesis™ Platform at..
20/10/202305:05GLOBECodexis to Report Third Quarter 2023 Financial Results on..
29/09/202320:05GLOBECodexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton..
23/09/202305:32EDGAR2Form 8-K - Current report
19/09/202305:05GLOBECodexis CEO Stephen Dilly Named as Finalist of 2023 Bloom..
13/09/202305:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/09/202305:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/09/202305:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/09/202305:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/09/202305:05GLOBECodexis to Participate in Cantor Global Healthcare..
08/09/202305:05EDGAR2Form 8-K - Current report
08/09/202305:05GLOBECodexis Announces Agreement for Assignment and Assumption of..
04/08/202305:54EDGAR2Form S-8 - Securities to be offered to employees in employee..

최근 히스토리

Delayed Upgrade Clock